Literature DB >> 23954273

Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.

Kimberly J Reidy1, Pardeep K Aggarwal2, Juan J Jimenez3, David B Thomas4, Delma Veron2, Alda Tufro5.   

Abstract

Semaphorin-3A (Sema3a), a guidance protein secreted by podocytes, is essential for normal kidney patterning and glomerular filtration barrier development. Here, we report that podocyte-specific Sema3a gain-of-function in adult mice leads to proteinuric glomerular disease involving the three layers of the glomerular filtration barrier. Reversibility of the glomerular phenotype upon removal of the transgene induction provided proof-of-principle of the cause-and-effect relationship between podocyte Sema3a excess and glomerular disease. Mechanistically, excess Sema3a induces dysregulation of nephrin, matrix metalloproteinase 9, and αvβ3 integrin in vivo. Sema3a cell-autonomously disrupts podocyte shape. We identified a novel direct interaction between the Sema3a signaling receptor plexinA1 and nephrin, linking extracellular Sema3a signals to the slit-diaphragm signaling complex. We conclude that Sema3a functions as an extracellular negative regulator of the structure and function of the glomerular filtration barrier in the adult kidney. Our findings demonstrate a crosstalk between Sema3a and nephrin signaling pathways that is functionally relevant both in vivo and in vitro.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23954273      PMCID: PMC3791681          DOI: 10.1016/j.ajpath.2013.06.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

Review 1.  Semaphorin regulation of cellular morphology.

Authors:  Tracy S Tran; Alex L Kolodkin; Rajnish Bharadwaj
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 2.  Properties of the glomerular barrier and mechanisms of proteinuria.

Authors:  Börje Haraldsson; Jenny Nyström; William M Deen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

3.  Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane.

Authors:  Rosa M Baleato; Petrina L Guthrie; Marie-Claire Gubler; Leonie K Ashman; Séverine Roselli
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

4.  Semaphorin3a disrupts podocyte foot processes causing acute proteinuria.

Authors:  R Tapia; F Guan; I Gershin; J Teichman; G Villegas; A Tufro
Journal:  Kidney Int       Date:  2007-12-12       Impact factor: 10.612

5.  Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network.

Authors:  Corina M Borza; Dorin-Bogdan Borza; Vadim Pedchenko; Moin A Saleem; Peter W Mathieson; Yoshikazu Sado; Heather M Hudson; Ambra Pozzi; Juan Saus; Dale R Abrahamson; Roy Zent; Billy G Hudson
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

6.  VEGF inhibition and renal thrombotic microangiopathy.

Authors:  Vera Eremina; J Ashley Jefferson; Jolanta Kowalewska; Howard Hochster; Mark Haas; Joseph Weisstuch; Catherine Richardson; Jeffrey B Kopp; M Golam Kabir; Peter H Backx; Hans-Peter Gerber; Napoleone Ferrara; Laura Barisoni; Charles E Alpers; Susan E Quaggin
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

7.  Advanced glycation end-products suppress neuropilin-1 expression in podocytes.

Authors:  Tzvetanka Bondeva; Christiane Rüster; Sybille Franke; Elke Hammerschmid; Michael Klagsbrun; Clemens D Cohen; Gunter Wolf
Journal:  Kidney Int       Date:  2008-11-26       Impact factor: 10.612

8.  Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.

Authors:  Dale R Abrahamson; Kathryn Isom; Eileen Roach; Larysa Stroganova; Adrian Zelenchuk; Jeffrey H Miner; Patricia L St John
Journal:  J Am Soc Nephrol       Date:  2007-08-15       Impact factor: 10.121

9.  Semaphorin3a inhibits ureteric bud branching morphogenesis.

Authors:  Alda Tufro; Jason Teichman; Craig Woda; Guillermo Villegas
Journal:  Mech Dev       Date:  2007-12-28       Impact factor: 1.882

10.  Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus.

Authors:  Keizo Kanasaki; Yoshiko Kanda; Kristin Palmsten; Harikrishna Tanjore; Soo Bong Lee; Valerie S Lebleu; Vincent H Gattone; Raghu Kalluri
Journal:  Dev Biol       Date:  2007-11-12       Impact factor: 3.582

View more
  12 in total

1.  Inhibitory effects of Semaphorin 3F as an alternative candidate to anti-VEGF monoclonal antibody on angiogenesis.

Authors:  Gamze Tan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-16       Impact factor: 2.416

2.  SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion.

Authors:  Xueping Fan; Hongying Yang; Sudhir Kumar; Kathleen E Tumelty; Anna Pisarek-Horowitz; Hila Milo Rasouly; Richa Sharma; Stefanie Chan; Edyta Tyminski; Michael Shamashkin; Mostafa Belghasem; Joel M Henderson; Anthony J Coyle; David J Salant; Stephen P Berasi; Weining Lu
Journal:  JCI Insight       Date:  2016-11-17

3.  Inhibition of semaphorin-3a suppresses lipopolysaccharide-induced acute kidney injury.

Authors:  Xiaofang Tian; Hua Gan; Yizhou Zeng; Hongfei Zhao; Rong Tang; Yunfeng Xia
Journal:  J Mol Med (Berl)       Date:  2018-06-16       Impact factor: 4.599

Review 4.  Semaphorin3a signaling, podocyte shape, and glomerular disease.

Authors:  Alda Tufro
Journal:  Pediatr Nephrol       Date:  2014-01-26       Impact factor: 3.714

5.  Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.

Authors:  Delma Veron; Pardeep K Aggarwal; Heino Velazquez; Michael Kashgarian; Gilbert Moeckel; Alda Tufro
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

6.  Podocyte Shape Regulation by Semaphorin 3A and MICAL-1.

Authors:  Alda Tufro
Journal:  Methods Mol Biol       Date:  2017

7.  Rho-GTPase Activating Protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis.

Authors:  Qi Li; Ashima Gulati; Mathieu Lemaire; Timothy Nottoli; Allen Bale; Alda Tufro
Journal:  Kidney Int       Date:  2021-01-04       Impact factor: 10.612

8.  Semaphorin3a promotes advanced diabetic nephropathy.

Authors:  Pardeep K Aggarwal; Delma Veron; David B Thomas; Dionicio Siegel; Gilbert Moeckel; Michael Kashgarian; Alda Tufro
Journal:  Diabetes       Date:  2014-12-04       Impact factor: 9.461

Review 9.  Role of Neuropilin-1 in Diabetic Nephropathy.

Authors:  Tzvetanka Bondeva; Gunter Wolf
Journal:  J Clin Med       Date:  2015-06-17       Impact factor: 4.241

10.  FAT1 mutations cause a glomerulotubular nephropathy.

Authors:  Heon Yung Gee; Carolin E Sadowski; Pardeep K Aggarwal; Jonathan D Porath; Toma A Yakulov; Markus Schueler; Svjetlana Lovric; Shazia Ashraf; Daniela A Braun; Jan Halbritter; Humphrey Fang; Rannar Airik; Virginia Vega-Warner; Kyeong Jee Cho; Timothy A Chan; Luc G T Morris; Charles ffrench-Constant; Nicholas Allen; Helen McNeill; Rainer Büscher; Henriette Kyrieleis; Michael Wallot; Ariana Gaspert; Thomas Kistler; David V Milford; Moin A Saleem; Wee Teik Keng; Stephen I Alexander; Rudolph P Valentini; Christoph Licht; Jun C Teh; Radovan Bogdanovic; Ania Koziell; Agnieszka Bierzynska; Neveen A Soliman; Edgar A Otto; Richard P Lifton; Lawrence B Holzman; Nicholas E S Sibinga; Gerd Walz; Alda Tufro; Friedhelm Hildebrandt
Journal:  Nat Commun       Date:  2016-02-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.